...achhhhh,,,the .40+ cent entry level this am is looking good right now,,,,,,,,I am not letting go of any of them either,,,,the FDA is not the only game in town,,,,,,,most junior biotechs can only dream of having interesting data on such disease as what our secondary end points might point to,,,,,,,,,,,,,bring it on DM and gang!!